6446 PharmaEssentia
PharmaEssentia announced on May 25, 2026, the completion of a capital reduction by canceling restricted employee shares. The reduction involves 8,000 shares, with minimal impact on financial statements.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 06:31
- 🔍 Collected: May 26, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:13 (133h 41m after Collected)
PharmaEssentia announced the completion of the registration for capital reduction due to the cancellation of restricted employee shares on May 25, 2026. The regulatory approval and registration completion date was May 25, 2026. The paid-in capital changed from 3,799,093,700 TWD to 3,799,013,700 TWD. The net value per share remains at 92.71 TWD. A total of 8,000 shares were canceled.
FAQ
What is the purpose of the capital reduction?
To cancel restricted employee shares.